Clinical Trials Logo

Fidaxomicin clinical trials

View clinical trials related to Fidaxomicin.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT02667418 Recruiting - Vancomycin Clinical Trials

Optimal Treatment for Recurrent Clostridium Difficile

OpTION
Start date: December 21, 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether fidaxomicin and vancomycin followed by taper and pulse vancomycin treatment are superior to standard vancomycin treatment for the treatment of recurrent Clostridium difficile infection.